Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Dementia With Lewy Bodies or REM Sleep Behavior Disorder

Birmingham Alabama 35294

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

Tuscaloosa Alabama 35404

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Arizona

Xenoscience
Phoenix Arizona 85004

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Territory Neurology & Research Institute
Tucson Arizona 85704

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

Phoenix Arizona 85032

A clinical research study of AVP-786 and Placebo for the treatment of Agitation in Patients With Dementia of the Alzheimer's Type

UPDATED

Phoenix Arizona 85005

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)

UPDATED

Phoenix Arizona 85006

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

UPDATED

Phoenix Arizona 85013

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

UPDATED

Phoenix Arizona 85004

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Alzheimer's Disease

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

Scottsdale Arizona 85260

A Phase 3 clinical study for patients with Alzheimer's Disease

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Sun City Arizona 85351

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Tucson Arizona 85704

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)

UPDATED

Tucson Arizona 85704

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Tucson Arizona 85718

A Phase 3 clinical study for patients with Alzheimer's Disease

Arkansas

Fayetteville Arkansas

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

Jonesboro Arkansas 72401

A Phase 3 clinical study for patients with Alzheimer's Disease

Springdale Arkansas 72764

A Phase 3 clinical study for patients with Alzheimer's Disease

California

Pharmacology Research Institute, Encino
Encino California 91316

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Alliance Research Center
Laguna Hills California 92653

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Renew Behavioral Health, Inc.
Long Beach California 90807

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Excell Research, Inc.
Oceanside California 92056

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Asclepes Research Center
Panorama City California 91402

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

Patients with Mild-Moderate Alzheimer's Disease

Sharp Mesa Vista Hospital Clinical Research Center
San Diego California 92123

This study is a Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease.

Schuster Medical Research Institute
Sherman Oaks California 91403

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).

View More ▼

Anaheim California 92805

A Phase 3 clinical study for patients with Alzheimer's Disease

Bellflower California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

Carlsbad California 92011

A Phase 3 clinical study for patients with Alzheimer's Disease

Costa Mesa California 92627

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Costa Mesa California

Patients are needed to participate in a clinical research study evaluating E2609 and Placebo for the treatment of Alzheimer Disease or Dementia, Alzheimer Type

UPDATED

Encino California 91436

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)

UPDATED

Fountain Valley California 92708

A Phase 2 clinical study for patients with Lewy Body Dementia or Visual Hallucinations

Fremont California 94538

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Fresno California 93710

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Fullerton California 92835

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease (MINDSET Study)